FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

417011002: Pneumococcal polysaccharide vaccine (substance)


    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2020. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    2547221013 Pneumococcal polysaccharide vaccine (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    2549556018 Pneumococcal polysaccharide vaccine en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3267831000005110 pneumokok-polysakkarid-vaccine da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)


    0 descendants.

    Expanded Value Set


    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    pneumokok-polysakkarid-vaccine Is a pneumokokvaccine false Inferred relationship Some

    Inbound Relationships Type Active Source Characteristic Refinability Group
    7-valent konjugeret pneumokokvaccine The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False pneumokok-polysakkarid-vaccine Inferred relationship Some 1
    polyvalent pneumokokvaccine The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False pneumokok-polysakkarid-vaccine Inferred relationship Some 1
    subkutan injektion af Pneumovax II Direct substance False pneumokok-polysakkarid-vaccine Inferred relationship Some 1
    pneumokokpolysaccharidvaccine The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False pneumokok-polysakkarid-vaccine Inferred relationship Some 1
    konjugeret pneumokokpolysaccharidvaccine The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False pneumokok-polysakkarid-vaccine Inferred relationship Some 1
    pneumokokpolysaccharidvaccine 25 µg injektionsvæske, opløsning, hætteglas a 0,5 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False pneumokok-polysakkarid-vaccine Inferred relationship Some
    polyvalent pneumokokvaccine, injektionsvæske, opløsning, sprøjte a 0.5 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False pneumokok-polysakkarid-vaccine Inferred relationship Some
    pneumokokpolysaccharidvaccine 25 µg injektionsvæske, opløsning, sprøjte a 0,5 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False pneumokok-polysakkarid-vaccine Inferred relationship Some
    polyvalent pneumokokvaccine, injektionsvæske, opløsning, hætteglas a 2,5 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False pneumokok-polysakkarid-vaccine Inferred relationship Some
    pneumokokpolysaccharidvaccine 25 µg/0,5 ml injektionsvæske, opløsning, hætteglas a 0,5 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False pneumokok-polysakkarid-vaccine Inferred relationship Some
    pneumokokpolysaccharidvaccine 25 µg/0,5 ml injektionsvæske, opløsning, sprøjte a 0,5 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False pneumokok-polysakkarid-vaccine Inferred relationship Some
    subkutan injektion af Pneumovax II Direct substance False pneumokok-polysakkarid-vaccine Inferred relationship Some 1
    Administration of pneumococcal polysaccharide 23 valent vaccine Direct substance False pneumokok-polysakkarid-vaccine Inferred relationship Some 1
    polyvalent pneumokokvaccine, injektionsvæske, opløsning, sprøjte a 0.5 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False pneumokok-polysakkarid-vaccine Inferred relationship Some 1

    Reference Sets

    Concept inactivation indicator reference set

    GB English

    POSSIBLY EQUIVALENT TO association reference set (foundation metadata concept)

    Back to Start